CCR4 antagonists inhibit regulatory T cell (Treg) recruitment and increase effector T cell (Teff) numbers in the tumor microenvironment potentiating an anti-tumor response

被引：0

作者：

Talay, Oezcan ^{[1
]}

Marshall, Lisa ^{[1
]}

Meleza, Cesar ^{[1
]}

Reilly, Maureen ^{[1
]}

Robles, Omar ^{[1
]}

Zibinsky, Mikhail ^{[1
]}

Okal, Abood ^{[1
]}

McKinnell, Jenny ^{[1
]}

Jacobson, Scott ^{[1
]}

Riegler, Erin ^{[1
]}

Marubayashi, Sashie ^{[1
]}

Karbarz, Emily ^{[1
]}

Chian, David ^{[1
]}

Wadsworth, Angela ^{[1
]}

Wustrow, David ^{[1
]}

Fridman, Jordan ^{[1
]}

Kassner, Paul ^{[1
]}

机构：

[1] FLX Bio Inc, San Francisco, CA USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P467

引用

页数：1

共 50 条

[31] B lymphocytes inhibit anti-tumor response in a murine EMT6 tumor model by facilitating expansion of T regulatory cells
Zhang, Yu
Tadmor, Tamar
Eliav, Yair
Schreiber, Taylor H.
Podack, Eckhard R.
Levy, Robert
Shin, Seung-uon
Rosenblatt, Joseph D.
CANCER RESEARCH, 2011, 71
[32] CD4+T cell help differentially influences anti-tumor immunity as a function of T cell avidity
Zhu, Ziqiang
Singh, Vinod
Bronte, Vincenzo
Feigenbaum, Lionel
Hurwitz, Arthur
CANCER RESEARCH, 2011, 71
[33] Combination immunotherapy integrating HSP90 inhibitor 17-DMAG reconditions the tumor microenvironment for improved T cell recruitment and anti-tumor efficacy
Rao, Aparna
Kawabe, Mayumi
Taylor, Jennifer
Storkus, Walter
JOURNAL OF IMMUNOLOGY, 2012, 188
[34] CCR4 Expression in Tumor-Infiltrating Regulatory T Cells in Patients with Squamous Cell Carcinoma of the Lung: A Prognostic Factor for Relapse and Survival
Asai, Nobuhiro
Kubo, Akihito
Suzuki, Susumu
Murotani, Kenta
Numanami, Hiroki
Yoshikawa, Kazuhiro
Ueda, Ryuzo
Yamaguchi, Etsuro
CANCER INVESTIGATION, 2019, 37 (03) : 163 - 173
[35] A local enrichment of regulatory T cells within the tumor tissue might suppress an effective anti-tumor T cell response in patients with head and neck cancer.
Cao, Y
Hegewisch-Becker, S
Blum, I
Bartels, K
Faltz, C
Leuwer, R
Atanackovic, D
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 877S - 877S
[36] Genetically acquired resistance to the T cell effector cytokine IFNγ limits anti-tumor immunity in melanoma
Sucker, A.
Zhao, F.
Heeke, C.
Block, N.
Maltaner, R.
Stadler, N.
Real, B.
Bielefeld, N.
Weide, B.
Gutzmer, R.
Utikal, J.
Trilling, M.
Horn, S.
Schilling, B.
Schadendorf, D.
Griewank, K.
Paschen, A.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 23 - 23
[37] Anti-tumor effector and mitochondrial function during cytotoxic T cell migration in metabolically challenging microenvironments
Dieteren, C. E. J.
Wagena, E.
Weigelin, B.
Scorrano, L.
Manjeri, G. R.
Willems, P. H. G. M.
Koopman, W. J. H.
Friedl, P.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 : 61 - 61
[38] Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance
Khan, Imran S.
Mouchess, Maria L.
Zhu, Meng-Lei
Conley, Bridget
Fasano, Kayla J.
Hou, Yafei
Fong, Lawrence
Su, Maureen A.
Anderson, Mark S.
JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 211 (05): : 761 - 768
[39] Combinatorial Antigen Targeting: Ideal T-Cell Sensing and Anti-Tumor Response
Themelil, Maria
Sadelain, Michel
TRENDS IN MOLECULAR MEDICINE, 2016, 22 (04) : 271 - 273
[40] ER-Golgi Network Regulates Anti-Tumor T Cell Immunotherapeutic Response
Oberholtzer, Nathaniel
Chakraborty, Paramita
Kassir, Mohamed Faisal
Mills, Stephanie
Comte-Walters, Susana
Gooz, Monika
Hedley, Zacharia
Vaena, Silvia
Romeo, Martin
Berto, Stefano
Demass, Reid
Scurti, Gina
Hill, Elizabeth
Ball, Lauren
Maldonado, Eduardo
Nishimura, Michael
Ogretmen, Besim
JOURNAL OF IMMUNOLOGY, 2024, 212 (01):

← 1 2 3 4 5 →